Evidence map›Paper›PMID 37693490›Full record

ArticlemedRxiv : the preprint server for health sciences2023

Hyejeong Hong, Kimberly A Dill-McFarland, Jason D Simmons, Glenna J Peterson, Penelope Benchek, Harriet Mayanja-Kizza, W Henry Boom, Catherine M Stein, Thomas R Hawn

Open access · greenAbstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

  • Updated by
    2024
5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Hyejeong HongDepartment of Biobehavioral Health Sciences, School of Nursing, University of Pennsylvania, Philadelphia, PA, USA.
Kimberly A Dill-McFarlandDepartment of Medicine, University of Washington, Seattle, WA, USA.
Jason D SimmonsDepartment of Medicine, University of Washington, Seattle, WA, USA.
Glenna J PetersonDepartment of Medicine, University of Washington, Seattle, WA, USA.
Penelope BenchekDepartment of Population & Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USA.
Harriet Mayanja-KizzaDepartment of Medicine, School of Medicine, Makerere University, Kampala, Uganda.
W Henry BoomDepartment of Medicine, Case Western Reserve University, Cleveland, OH, USA.
Catherine M SteinDepartment of Population & Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USA.
Thomas R HawnDepartment of Medicine, University of Washington, Seattle, WA, USA.
University of Washington · USCase Western Reserve University · USMakerere University · UGUniversity of Pennsylvania · US

Funding

IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB)75N93019C00071 · NIAID · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI FORTUNE, SARAH · 2019 to 2025
$57.3M
HOST DEFENSE TRAINING IN ALLERGY AND INFECTIOUS DISEASEST32AI007044 · NIAID · UNIVERSITY OF WASHINGTON · PI DAVID Neal FREDRICKS · 1985 to 2026
$14.6M
Systems Biology, Bioinformatics, & Data IntegrationU19AI162583 · NIAID · UNIVERSITY OF WASHINGTON · PI DUNSTAN, SARAH JANE · 2021 to 2025
$13.0M
Resistance to MTB infection in HIV infected individuals in Uganda and S. AfricaR01AI124348 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI BOOM, W. HENRY, HAWN, THOMAS R · 2016 to 2020
$11.3M
Natural Resistance to Mycobacterium Tuberculosis InfectionU01AI115642 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI BOOM, W. HENRY, MAYANJA-KIZZA, HARRIET · 2015 to 2019
$3.5M
Epigenetic & Post-Translational Mechanisms of Macrophage Resistance to Mycobacterium tuberculosis During HIV Co-InfectionR33AI138272 · NIAID · UNIVERSITY OF WASHINGTON · PI BOOM, W. HENRY, HAWN, THOMAS R · 2020 to 2022
$3.4M
Omics and Symptom Science Training ProgramT32NR016913 · NINR · UNIVERSITY OF WASHINGTON · PI CYNTHIA M DOUGHERTY, Margaret McLean Heitkemper · 2017 to 2026
$3.2M
Macrophages and Resistance to Mycobacterium Tuberculosis Infection in HumansK08AI143926 · NIAID · UNIVERSITY OF WASHINGTON · PI SIMMONS, JASON · 2019 to 2023
$951k
Pulmonary Innate Immunity & Resistance to Mycobacterium Tuberculosis InfectionK24AI137310 · NIAID · UNIVERSITY OF WASHINGTON · PI HAWN, THOMAS R · 2018 to 2022
$892k
NIAID NIH HHS 75N93019C00071NIAID NIH HHS K08 AI143926NIAID NIH HHS K24 AI137310NIAID NIH HHS N01 AI070022NIAID NIH HHS R01 AI124348NIAID NIH HHS R33 AI138272NIAID NIH HHS T32 AI007044NIAID NIH HHS U01 AI115642NIAID NIH HHS U19 AI162583NINR NIH HHS T32 NR016913
6 · The paper itself

Abstract

The heterogeneity of outcomes after

Indexed as

expression quantitative trait locimonocyte responseMycobacterium tuberculosispro-inflammatory cytokine

Identifiers

PMID37693490
PMCPMC10491362
OpenAlexW4386294235

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.